Norwegian Mental Illness Heart Health Study

Recruiting N/A Interventional Study
Cardio Vascular Disease Metabolic Syndrome (MetS) Severe Mental Disorder Schizophrenia and Schizophrenia Spectrum Psychosis Bipolar Disease Type I Overweight and/or Obesity CVD Risk Factors Severe Mental Illness
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 – 70
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
70 (estimated)
Sponsor
Madeleine Elisabeth Angelsen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Norwegian patients with severe mental illnesses (SMI), such as schizophrenia spectrum or bipolar disorder, lose on average 10 years of life compared to mentally healthy individuals. Much of this gap is due to heart disease. Unhealthy lifestyle habits, including poor diet and physical inactivity, contribute to higher levels of metabolic risk factors for heart disease in this population. The goal o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of F20-29 (schizophrenia spectrum) or F31 (bipolar affective disorder) * Current use of antipsychotic medication (first- or second generation) or lithium * Body Mass Index \> or = 27 kg/m\^2 Exclusion Criteria: Psychiatric condition: * Inability to provide informe…
Contacts

Madeleine E Angelsen, M.Sc. Clinical Nutrition

+4747234028

m.e.angelsen@studmed.uio.no

CONTACT

Professor Kjetil Retterstøl, Professor, MD

+47 90098393

kjetil.retterstol@medisin.uio.no

CONTACT